Skip to content
healthcare.dev
Get a free key

BIXLENVO

NDC 61958-3601, bictegravir/lenacapavir, tablet, film coated, from Gilead Sciences, Inc..

Product NDC
61958-3601
Status
Listed
Labeler
Gilead Sciences, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA221104
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61958-3601 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BICTEGRAVIR SODIUM75 mg/1
  • LENACAPAVIR SODIUM50 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; HIV Capsid Inhibitors [MoA]; Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
61958-3601-16195836010130 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-3601-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/072a3c7e-33fb-4a87-ba21-3d8dad3f5c48

Use it

Look up 61958-3601 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61958-3601 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61958-3601. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.